MedPath

Virechana followed by Snehapana in Amavata Rheumatoid Arthritis

Phase 2/3
Not yet recruiting
Conditions
Rheumatoid arthritis with rheumatoid factor, unspecified. Ayurveda Condition: AMAVATAH,
Registration Number
CTRI/2025/04/085603
Lead Sponsor
Government Akhandanand Ayurved College, Ahmedabad
Brief Summary

*Amavata* is the particular type of disease which is the mentioned in Ayurveda since the period of *Madhavakara* 16th century A.D. under the category of Vata Kaphaja disorders. Amavata develops due to Dushti or Prakopa of Ama as well as Vata dosha. The clinical presentation of *Amavata* closely mimics with the special variety of rheumetological disorders called rheumatoid arthritis (R.A.), in accordance with their similaritis on clinical features, like pain , swelling .stiffness, fever, redness, general debility are almost identical.The rheumatological disorder is such a group of diseases which has no specific medical management in any type of therapeutics. *Amavata* is the prime disease which makes the person unfit for an independent life and about 60% of the patients become unfit to work 10 years after the onset of the disease. The Ayurvedic approach toward the treatment of *Amavata* is the need of our as no system is successful in providing a complete cure to this disease

For the treatment of Amavata Acharya Chakradutta and Acharya Bhavmishra explained that Langhana, Swedana , Dipana with Tikta and Katu Rasapradhan dravya and *Virechana* followed by Shamana Snehpana

After *Langhana*, S*wedana* and *Tika, Katu, Deepana dravyas, doshas* Attain *nirama avastha* and may require elimination from the body by *shodhana.* Symptoms of *Amavata* like *Anaha, vibandha, Antrakujana, kukshishula* etc. are indicated of *pratiloma gati* of *vata*. This is best conquered by *Virechana.*

Dipana Yoga (Vaishvaner Churna) having Tikta and Katu rasatmaka, Ushna,Tikshna, Sukshma, gunatmaka.They have qualities of Dipana , Pachana and Anulomaka, which helps in the Pachana of Ama and subsides the aggravate Vata dosha.

Amrita Shunthi Ghrita is for Shodhanartha helps to subsides Amavata and prepare the body for Virechana to carry the doshas from Shakha to Kostha.

Virechana with Trvrittadi churna is recommended treatment for Amavata after Deepana Pachana which also helps to subsides aggravated vata in Amavata.

Acharya Vagbhata mentioned in Sutrasthana chapter 16 that after Shodhan karma, Snehana should be advised for Bala.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Either sex with age greater than or equal to 18 years and less than or equal to 60 years The Willingness and able to participate of the patients in the study Patient having signs and symptoms of Amavata Rheumatoid arthritis with fulfilling Diagnostic criteria Chronicity less than 10 years and more than 1 year.

Exclusion Criteria

Patients below 18 years and above 60 years Pregnant or lactating women Snehana Ayogya patients Virechana Ayogya patients Chronicity More than 10 years Known Case of Severe Heart Diseases Kidney Diseases Stroke Liver Diseases Uncontrolled diabetes and Carcinogenic conditions Known Case Of Pulmonary Dysfunction or COPD History of any acute or chronic infectious diseases like TB AIDS Other STDs Taking medications like corticosteroids hormonal therapy Anti depressants or any other drugs which may affect outcome of the study With alcohol addiction or drug abuse Acute Amavata less than 1 year.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the symptoms of Amavata wsr Rheumatoid Arthritis30 to 48 days
Secondary Outcome Measures
NameTimeMethod
Improvement in the symptoms of Amavata wsr Rheumatoid Arthritis5th to 15th day

Trial Locations

Locations (1)

Government Akhandanand Ayurved College And Hospital

🇮🇳

Ahmadabad, GUJARAT, India

Government Akhandanand Ayurved College And Hospital
🇮🇳Ahmadabad, GUJARAT, India
Dr Pranav Pandya
Principal investigator
9173677855
pranavpandya791@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.